Effect of Vit E, Vit B6, Calcium and Omega-3 on Treatment of Premenstrual Syndrome.

Phase 2

• Conditions: Premenstrual syndrom.; Premenstrual Tension Syndrome

• Registration Number: IRCT2012123010705N1
• Lead Sponsor: Vice Chancellor for Research, Islamic Azad University Sari Branch, Darya Bolvar, Khazar Square, Sari

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 200

Inclusion Criteria

Inclusion Criteria:
Single Girls, Aged Between 18-30 Years Old, Having Regular Menstrual Cycles, Duration of the Cycle Between 21-35 Days, Having Moderate and Sever Form of Premenstrual Syndrome According to the Standard Questionnaire of Rosignol Bonlender.

Exclusion Criteria

Breast Feeding, Use of Oral Contraceptive Pills, Having a History of Psychological Diseases Such as Depression, Traumatic Problems During the Past Two Months, Taking Antidepressants and Herbal Drugs 6 Months Ago.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Severity of Premenstrual Syndrom. Timepoint: Before and Three Months After Treatment. Method of measurement: Rosignol Bonlender Questionnair & Checklist.

Secondary Outcome Measures

Name	Time	Method
Severity of Physical Symptoms of Premenstrual Syndrom. Timepoint: Before Treatment and Three Months After Treatment. Method of measurement: Rosignol Bonlender Questionnaire.;Severity of Psycological Symptoms of Premenstrual Syndrom. Timepoint: Before Treatment and Three Months After Treatment. Method of measurement: Rosignol Bonlender Questionnaire.;Severity of Premenstrual Syndrom. Timepoint: Before Treatment and Three Months After Treatment. Method of measurement: Rosignol Bonlender Questionnaire.